Litigation Details for Apple Inc. v. Masimo Corporation (Fed. Cir. 2022)
✉ Email this page to a colleague
Apple Inc. v. Masimo Corporation (Fed. Cir. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-06-10 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,505,059 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Apple Inc. v. Masimo Corporation
The biologic drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Apple Inc. v. Masimo Corporation (Fed. Cir. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-02-15 | 22 | 7,142,901 B2 11/2006 Kiani et al. 6,505,059 Bl 1/2003 Kollias et al. …THE UNITED STATES PATENT AND TRADEMARK OFFICE In re Patent of: Al-Ali U.S. Patent No.: 8,457,703…PULSE OXIMETER Mail Stop Patent Board Patent Trial and Appeal Board U.S. Patent and Trademark Office P.…Challenged Claims”) of U.S. Patent No. 8,457,703 (“the ’703 Patent”). The ’703 Patent describes a purported… The ’703 Patent is in the same family as U.S. Patent No. 10,433,776 (“the ’776 Patent”). Apple has | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
